These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

985 related articles for article (PubMed ID: 26687069)

  • 1. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms.
    Sahora K; Crippa S; Zamboni G; Ferrone C; Warshaw AL; Lillemoe K; Mino-Kenudson M; Falconi M; Fernandez-del Castillo C
    Eur J Surg Oncol; 2016 Feb; 42(2):197-204. PubMed ID: 26687069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic neuroendocrine tumors among patients with intraductal papillary mucinous neoplasms: real association or just a coincidence?
    Gill KR; Scimeca D; Stauffer J; Krishna M; Woodward TA; Jamil LH; Wallace MB; Nguyen JH; Raimondo M
    JOP; 2009 Sep; 10(5):515-7. PubMed ID: 19734627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraductal papillary-mucinous adenocarcinoma in the remnant pancreas after pancreatoduodenectomy for cancer of Vater's papilla associated with intraductal papillary-mucinous adenoma.
    Ishida M; Egawa S; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Furukawa T; Unno M
    J Hepatobiliary Pancreat Surg; 2007; 14(5):522-5. PubMed ID: 17909725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Branch duct intraductal papillary mucinous neoplasm - contra resection].
    Brunner M; Weber GF; Kersting S; Grützmann R
    Chirurg; 2017 Nov; 88(11):918-926. PubMed ID: 28871376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
    Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
    Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invaginated ampulla of Vater in synchronous malignant intraductal papillary mucinous neoplasm of the pancreas and common bile duct cancer.
    Han JW; Jang SI; Ma DW; Yoon SO; Lee DK
    Endoscopy; 2013; 45 Suppl 2 UCTN():E25-6. PubMed ID: 23468151
    [No Abstract]   [Full Text] [Related]  

  • 7. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
    Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
    Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
    Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm.
    Tanno S; Nakano Y; Sugiyama Y; Nakamura K; Sasajima J; Koizumi K; Yamazaki M; Nishikawa T; Mizukami Y; Yanagawa N; Fujii T; Obara T; Okumura T; Kohgo Y
    Pancreatology; 2010; 10(2-3):173-8. PubMed ID: 20484955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas.
    Pea A; Yu J; Rezaee N; Luchini C; He J; Dal Molin M; Griffin JF; Fedor H; Fesharakizadeh S; Salvia R; Weiss MJ; Bassi C; Cameron JL; Zheng L; Scarpa A; Hruban RH; Lennon AM; Goggins M; Wolfgang CL; Wood LD
    Ann Surg; 2017 Jul; 266(1):133-141. PubMed ID: 27433916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
    Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of intraductal papillary mucinous neoplasm in patients with and without pancreas cancer.
    Macari M; Eubig J; Robinson E; Megibow A; Newman E; Babb J; Pachter HL; Hajdu C
    Pancreatology; 2010; 10(6):734-41. PubMed ID: 21252588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
    Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
    Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm.
    Malleo G; Marchegiani G; Borin A; Capelli P; Accordini F; Butturini G; Pederzoli P; Bassi C; Salvia R
    Ann Surg; 2015 May; 261(5):984-90. PubMed ID: 25493361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant pancreatic endocrine neoplasm and intraductal papillary mucinous neoplasm: a case report and literature review.
    Kadota Y; Shinoda M; Tanabe M; Tsujikawa H; Ueno A; Masugi Y; Oshima G; Nishiyama R; Tanaka M; Mihara K; Abe Y; Yagi H; Kitago M; Itano O; Kawachi S; Aiura K; Tanimoto A; Sakamaoto M; Kitagawa Y
    World J Surg Oncol; 2013 Mar; 11():75. PubMed ID: 23517520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S; Schirren M; Klauss M; Bergmann F; Hackert T; Hartwig W; Strobel O; Grenacher L; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
    Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
    Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
    McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
    Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
    Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Neuroendocrine Neoplasm Concomitant with Branch-duct Intraductal Papillary Mucinous Neoplasm: A Case Report and Literature Review.
    Sawai Y; Asada M; Marusawa H
    Intern Med; 2024 Sep; 63(17):2427-2432. PubMed ID: 38296477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.